Bacterial Resistance to Antibiotics: Mechanisms and Prevalence in Hospitals and Nursing Homes

DICP ◽  
1989 ◽  
Vol 23 (7-8) ◽  
pp. 556-561 ◽  
Author(s):  
John A. Bosso
Keyword(s):  
Nursing Homes ◽  
Bacterial Resistance ◽  
Resistance Mechanisms ◽  
Resistance To Antibiotics

Bacterial resistance to antibiotics has become an increasingly distressing problem over the last few decades. In this article, known resistance mechanisms are reviewed and the extent of the problem in both hospitals and nursing homes is addressed. Suggestions for preventing the further spread of this problem are presented.

Insights in Nanoparticle-Bacterium Interactions: New Frontiers to Bypass Bacterial Resistance to Antibiotics

2015 ◽  
Vol 21 (28) ◽  
pp. 4095-4105 ◽  
Author(s):  
Roudayna Diab ◽  
Bahman Khameneh ◽  
Olivier Joubert ◽  
Raphael Duval
Keyword(s):  
Bacterial Resistance ◽  
Resistance To Antibiotics

Assessment of the correctness of identification and determination of antimicrobial susceptibility of Streptococcus pneumoniae in microbiological laboratories in Poland

2020 ◽  
Vol 55 (4) ◽  
pp. 271-276
Author(s):  
Ewa Młodzińska ◽  
Waleria Hryniewicz
Keyword(s):  
Quality Control ◽  
Antimicrobial Susceptibility ◽  
Bacterial Resistance ◽  
External Quality Assessment ◽  
Resistance Mechanisms ◽  
Medical Problems ◽  
External Quality ◽  
External Quality Assessment Scheme ◽  
Reliable Identification

The increase in bacterial resistance to antimicrobials is one of the most serious medical problems, therefore reliable identification in microbiological laboratories is important. The Polish National External Quality Assessment Scheme in Microbiological Diagnostics – POLMICRO programme is organized by the Centre of Quality Control in Microbiology (CQCM) enables the assessment of the competence of Polish microbiological laboratories in the field of identification, determination of susceptibility and detection of drug resistance mechanisms. This work presents the assessment of the results of identification and determination of S. pneumoniae antimicrobial susceptibility obtained by Polish laboratories during the 20 years of experience of the POLMICRO programme.

scholarly journals Analisis Mutasi pada Kodon 531 Pada Gen Rpob Mycobacterium tuberculosis Penyebab Resistensi Rifampisin

2017 ◽  
Vol 15 (2) ◽  
pp. 140
Author(s):  
Yatnita Parama Cita ◽  
Dwi Hilda Putri
Keyword(s):  
Mycobacterium Tuberculosis ◽  
Bacterial Resistance ◽  
Rpob Gene ◽  
Resistance Mechanisms ◽  
Primer Design ◽  
Reference Sequence ◽  
Multi Drug Resistance ◽  
Accession Number ◽  
Chemotherapy Agent ◽  
Primer Design Program

Tuberculosis (TB) is a serious disesase in the world. According to the WHO, it is estimated more than 3 million people die every year as a result of this infectious disease. One factor that causes diffi culty handling TB chemoteraphy is not effective against the bacteria Mycobacterium tuberculosis that causes TB . Effectiveness of treatment is often hampered by the emergence of bacterial resistance against M. Tuberculosis chemotherapy agents are given. From some research found that bacterial resistance may occur in more one type of chemotherapy agent also known as multi-drug resistance (MDR). Mycobacterium tuberculosis develop resistance mechanisms that are different from other bacteria in general. In prokaryotes, resistance is generally due to the transfer of genetic, either through plasmids,transposons and other. Reference sequence beta sub unit of RNAP protein M. Tuberculosis with accession number NP_215181.1 and M. tucerculosis rpoB gene with accession number NC_000962.3 used to obtain preliminary information from the data base www.ncbi.nlm.gov and www.uniprot.org . Mutation done according to several studies literature. Analysis of the composition, profi le, location and structure of protein using www.expasy.org, TMHMM and http://bioinf.cs.ucl.ac.uk/psipred. The primer design is done with Primer Design Program. Based on the analysis of mutation in the beta subunit of RNAP protein M. Tuberculosis, codon 531 (Ser ->Leu), it is known that mutations cause changes in some properties and structure of proteins. Possible changes affecting the nature of bacterial resistance to antibiotics rifampicin. However, further analysis needs to be done with the analysis of the docking technique.

scholarly journals Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms

2016 ◽  
Vol 60 (10) ◽  
pp. 6067-6075 ◽  
Author(s):  
Jun Hong ◽  
Jianye Hu ◽  
Fei Ke
Keyword(s):  
Antimicrobial Peptide ◽  
Bacterial Resistance ◽  
Antimicrobial Agents ◽  
Resistance Mechanisms ◽  
Cross Resistance ◽  
Antibacterial Drug ◽  
Cationic Antimicrobial Peptide ◽  
Content Type ◽  
Tachyplesin I

ABSTRACTTachyplesin I is a 17-amino-acid cationic antimicrobial peptide (AMP) with a typical cyclic antiparallel β-sheet structure that is a promising therapeutic for infections, tumors, and viruses. To date, no bacterial resistance to tachyplesin I has been reported. To explore the safety of tachyplesin I as an antibacterial drug for wide clinical application, we experimentally induced bacterial resistance to tachyplesin I by using two selection procedures and studied the preliminary resistance mechanisms.Aeromonas hydrophilaXS91-4-1,Pseudomonas aeruginosaCGMCC1.2620, andEscherichia coliATCC 25922 and F41 showed resistance to tachyplesin I under long-term selection pressure with continuously increasing concentrations of tachyplesin I. In addition,P. aeruginosaandE. coliexhibited resistance to tachyplesin I under UV mutagenesis selection conditions. Cell growth and colony morphology were slightly different between control strains and strains with induced resistance. Cross-resistance to tachyplesin I and antimicrobial agents (cefoperazone and amikacin) or other AMPs (pexiganan, tachyplesin III, and polyphemusin I) was observed in some resistant mutants. Previous studies showed that extracellular protease-mediated degradation of AMPs induced bacterial resistance to AMPs. Our results indicated that the resistance mechanism ofP. aeruginosawas not entirely dependent on extracellular proteolytic degradation of tachyplesin I; however, tachyplesin I could induce increased proteolytic activity inP. aeruginosa. Most importantly, our findings raise serious concerns about the long-term risks associated with the development and clinical use of tachyplesin I.

Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them

2016 ◽  
Vol 95 ◽  
pp. 32-42 ◽  
Author(s):  
Bahman Khameneh ◽  
Roudayna Diab ◽  
Kiarash Ghazvini ◽  
Bibi Sedigheh Fazly Bazzaz
Keyword(s):  
Bacterial Resistance ◽  
Resistance Mechanisms
Sign in / Sign up

Export Citation Format

Share Document